ODYSSEY THERAPEUTICS
Live / Applied — Fifth extension granted (statement of use) (as of 01 Apr 2026)
What this means for you
Not registered yet, but its 08 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97668318
- Mark type
- Stylized text
- Filed
- 08 Nov 2022
- Published for opposition
- 24 Oct 2023
- Attorney of record
- Marie Lavalleye
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations for the treatment of auto-immune diseases; Molecules used as a component in pharmaceutical preparations for the treatment of auto-immune diseases
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the fields of pharmaceuticals, clinical trials, and auto-immune diseases; Development of molecules for use by others in developing and designing pharmaceutical products and preparations for the treatment of auto-immune diseases
Owner
- Odyssey Therapeutics, Inc., Boston, MA, US
- Odyssey Therapeutics, Inc., Boston, MA, US
Prosecution history
- 01 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2026 — SOU EXTENSION 5 GRANTED
- 31 Mar 2026 — SOU EXTENSION 5 FILED
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Oct 2025 — SOU EXTENSION 4 GRANTED
- 27 Oct 2025 — SOU EXTENSION 4 FILED
- 27 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2025 — SOU EXTENSION 3 GRANTED
- 15 May 2025 — SOU EXTENSION 3 FILED
- 01 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 May 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Oct 2024 — SOU EXTENSION 2 GRANTED